Zobrazit více v PubMed

Mutat Res. 1969 Jan-Feb;7(1):19-24 PubMed

Antimicrob Agents Chemother (Bethesda). 1965;5:982-91 PubMed

J Chromatogr. 1963 May;11:62-5 PubMed

J Gen Microbiol. 1956 Dec;15(3):599-608 PubMed

Antibiotiki (Mosc). 1958 Mar-Apr;3(2):18-21 PubMed

J Gen Microbiol. 1965 Jun;39(3):305-9 PubMed

J Hyg Epidemiol Microbiol Immunol. 1958;2(1):111-5 PubMed

J Am Pharm Assoc Am Pharm Assoc. 1949 Aug;38(8):473-5 PubMed

Proc Natl Acad Sci U S A. 1967 Sep;58(3):923-30 PubMed

Biochem Biophys Res Commun. 1965 Feb 3;18:325-31 PubMed

Experientia. 1964 Feb 15;20(2):83-4 PubMed

Can J Microbiol. 1967 Apr;13(4):389-95 PubMed

Characterization of an asporogenous mutant of Streptomyces aureofaciens with increased resistance to several aminoglycoside antibiotics

Alizarin glucosyl transferase activity in Streptomyces aureofaciens mutants

Microbial transformation of semisynthetic derivatives of daunomycinone modified in ring A

Microbial glucosidation of 1,2,4-trihydroxy-9,10-anthraquinone (purpurin)

Isolation, characterization and biological activities of verotetrone from a mutant strain of Streptomyces aureofaciens

Partial purification and properties of glucosyltransferase from Streptomyces aureofaciens

Mutants of Streptomyces coeruleorubidus impaired in the biosynthesis of daunomycinone glycosides and related metabolites

Isolation of glucosyltransferase from Streptomyces aureofaciens

The study of variability and strain selection in Streptomyces atroolivaceus. III. Isolation and preliminary characteristics of mutants impaired in the biosynthesis of mithramycin

Regulation of biosynthesis of secondary metabolites. XV. Isolation and characterization of auxotrophic mutants in Streptomyces aureofaciens

How many genes are required for the synthesis of chlortetracycline?